Yui K, Goto K, Ikemoto S, Ishiguro T, Kamada Y
Department of Psychiatry, Jichi Medical School, Tochigi, Japan.
Psychopharmacology (Berl). 1999 Aug;145(3):267-72. doi: 10.1007/s002130051058.
Increased sensitivity to stress associated with noradrenergic hyperactivity and dopaminergic changes may precipitate stress-related psychiatric disorders. The present study examines the relation between this increased sensitivity and vulnerability to subsequent spontaneous recurrences of methamphetamine (MAP) psychosis (i.e. flashbacks). Plasma monoamine metabolite levels were assayed in 18 subjects with flashbacks, of whom ten experienced a single flashback and eight experienced further subsequent flashbacks; in 21 subjects with a history of MAP psychosis who did not experience flashbacks; and 33 controls. A square-root transformation was applied to monoaminergic values, rendering the distribution normal. The subjects with flashbacks had undergone frightening stressful experiences during previous MAP use. The dominant factor triggering flashbacks was a mild fear of other people. During flashbacks, plasma noradrenaline levels markedly increased and 3-methoxytyramine levels, an indicator of dopamine release, were elevated. Among the 18 subjects with flashbacks, the ten with subsequent flashbacks had markedly increased noradrenaline levels during flashbacks, whereas the eight with a single flashback displayed small increases in noradrenaline levels as well as 3-methoxytyramine levels. Thus, a mild fear of other people may have elicited memories of MAP psychosis, related to frightening stressful experiences through increased sensitivity to stress associated with noradrenergic hyperactivity, involving increased dopamine release. Robust noradrenergic hyperreactivity to mild stress may predispose subjects to subsequent flashbacks.
与去甲肾上腺素能亢进和多巴胺能变化相关的应激敏感性增加可能会引发与应激相关的精神障碍。本研究探讨了这种敏感性增加与甲基苯丙胺(MAP)精神病后续自发复发(即闪回)易感性之间的关系。对18名有闪回症状的受试者的血浆单胺代谢物水平进行了检测,其中10人经历了单次闪回,8人随后又经历了闪回;21名有MAP精神病病史但未经历闪回的受试者;以及33名对照组。对单胺能值进行了平方根转换,使其分布呈正态。有闪回症状的受试者在之前使用MAP期间经历过可怕的应激经历。引发闪回的主要因素是对他人的轻微恐惧。在闪回期间,血浆去甲肾上腺素水平显著升高,多巴胺释放指标3-甲氧基酪胺水平也升高。在18名有闪回症状的受试者中,随后出现闪回的10人在闪回期间去甲肾上腺素水平显著升高,而仅经历一次闪回的8人去甲肾上腺素水平以及3-甲氧基酪胺水平仅有小幅升高。因此,对他人的轻微恐惧可能通过与去甲肾上腺素能亢进相关的应激敏感性增加,引发了与可怕应激经历相关的MAP精神病记忆,其中涉及多巴胺释放增加。对轻微应激的强烈去甲肾上腺素能高反应性可能使受试者易患后续闪回。